 Eligible patients will be randomized in a 1.1 ratio to receive Travoprost 0.004timolol 0.5 once daily or Latanoprost 0.005Timolol 0.5 once a day for 8 Weeks. The study treatments will be compared for mean diurnal intraocular pressure IOP change from baseline at Week 8. 